End-of-day quote
Shanghai S.E.
23:00:00 12/05/2024 BST
|
5-day change
|
1st Jan Change
|
10.98
CNY
|
0.00%
|
|
+1.39%
|
+0.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,801
|
7,828
|
11,291
|
8,266
|
6,195
|
6,173
|
-
|
-
|
Enterprise Value (EV)
1 |
4,801
|
7,828
|
11,291
|
8,266
|
6,195
|
6,173
|
6,173
|
6,173
|
P/E ratio
|
18.8
x
|
24.4
x
|
25.2
x
|
17.4
x
|
19.2
x
|
16
x
|
12.9
x
|
12.2
x
|
Yield
|
1.73%
|
-
|
0.52%
|
-
|
1.37%
|
3.19%
|
5.01%
|
-
|
Capitalization / Revenue
|
2.53
x
|
4.02
x
|
4.83
x
|
3.79
x
|
3.27
x
|
2.51
x
|
1.91
x
|
1.82
x
|
EV / Revenue
|
2.53
x
|
4.02
x
|
4.83
x
|
3.79
x
|
3.27
x
|
2.51
x
|
1.91
x
|
1.82
x
|
EV / EBITDA
|
12.9
x
|
17.3
x
|
18.8
x
|
13.1
x
|
12.9
x
|
10.7
x
|
8.69
x
|
7.91
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.04
x
|
4.22
x
|
5
x
|
3.32
x
|
2.33
x
|
2.04
x
|
1.73
x
|
1.69
x
|
Nbr of stocks (in thousands)
|
583,448
|
588,700
|
588,700
|
580,500
|
566,815
|
562,220
|
-
|
-
|
Reference price
2 |
8.228
|
13.30
|
19.18
|
14.24
|
10.93
|
10.98
|
10.98
|
10.98
|
Announcement Date
|
31/03/20
|
11/04/21
|
18/04/22
|
11/04/23
|
17/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,894
|
1,946
|
2,336
|
2,182
|
1,894
|
2,458
|
3,228
|
3,401
|
EBITDA
1 |
371.3
|
451.2
|
599.3
|
633
|
478.6
|
579.4
|
710.6
|
780
|
EBIT
1 |
293.9
|
366.6
|
512.5
|
539.8
|
367.4
|
459.8
|
577.9
|
603.6
|
Operating Margin
|
15.52%
|
18.84%
|
21.93%
|
24.74%
|
19.4%
|
18.7%
|
17.9%
|
17.75%
|
Earnings before Tax (EBT)
1 |
292.9
|
365.4
|
513.2
|
541.4
|
370.8
|
461.8
|
580.2
|
604.6
|
Net income
1 |
256.2
|
320.3
|
448.4
|
477.1
|
324.7
|
404.4
|
501.3
|
529.6
|
Net margin
|
13.52%
|
16.46%
|
19.19%
|
21.86%
|
17.14%
|
16.45%
|
15.53%
|
15.57%
|
EPS
2 |
0.4376
|
0.5448
|
0.7600
|
0.8200
|
0.5700
|
0.6850
|
0.8533
|
0.9000
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1427
|
-
|
0.1000
|
-
|
0.1500
|
0.3500
|
0.5500
|
-
|
Announcement Date
|
31/03/20
|
11/04/21
|
18/04/22
|
11/04/23
|
17/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17%
|
18.7%
|
21.7%
|
19.7%
|
12.4%
|
13.3%
|
13.9%
|
13.9%
|
ROA (Net income/ Total Assets)
|
12.2%
|
12.6%
|
15.5%
|
-
|
-
|
11.2%
|
11.7%
|
-
|
Assets
1 |
2,103
|
2,533
|
2,892
|
-
|
-
|
3,611
|
4,303
|
-
|
Book Value Per Share
2 |
2.710
|
3.150
|
3.830
|
4.290
|
4.680
|
5.370
|
6.350
|
6.490
|
Cash Flow per Share
2 |
0.1700
|
0.0600
|
0.0600
|
0.8200
|
0.5400
|
1.000
|
0.8400
|
1.540
|
Capex
1 |
30.7
|
56.9
|
202
|
171
|
199
|
271
|
279
|
416
|
Capex / Sales
|
1.62%
|
2.92%
|
8.66%
|
7.83%
|
10.49%
|
11.01%
|
8.64%
|
12.23%
|
Announcement Date
|
31/03/20
|
11/04/21
|
18/04/22
|
11/04/23
|
17/04/24
|
-
|
-
|
-
|
Last Close Price
10.98
CNY Average target price
12.74
CNY Spread / Average Target +16.03% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.46% | 854M | | +16.84% | 66.69B | | +1.79% | 49.2B | | +17.80% | 41.24B | | +20.17% | 25.89B | | +12.56% | 19.81B | | +3.13% | 17.11B | | -23.12% | 15.86B | | +2.62% | 15.35B | | -8.98% | 15.23B |
Other Specialty Chemicals
|